Giorgia Sulis profile picture

Contact Information

Giorgia Sulis, MD, PhD

Giorgia Sulis

Associate Scientist, Methodological & Implementation Research
Ottawa Hospital Research Institute
Assistant Professor, School of Epidemiology and Public Health
University of Ottawa
Member, McGill International Tuberculosis Centre
McGill University

Research Interests

1. Antibiotic prescribing and dispensing practices in primary care
2. Tuberculosis prevention
3. Vaccines and vaccination programs

Brief Biography

Dr. Giorgia Sulis is an Assistant Professor in the School of Epidemiology and Public Health at the University of Ottawa, an Associate Scientist in the Clinical Epidemiology Program of the Ottawa Hospital Research Institute and a Member of the McGill International Tuberculosis Centre. After receiving her medical degree (2011) and specializing in infectious and tropical diseases (2017) in Italy, she obtained a PhD in epidemiology from McGill University in 2021, followed by a postdoctoral research fellowship in the same university. 

Dr. Sulis' research interests span across various areas of infectious disease epidemiology of utmost global health relevance, with a special focus on four main themes: 1) antibiotic prescribing practices, particularly in resource-limited settings and with an emphasis on the primary level of care; 2) tuberculosis prevention and care, focusing primarily on the most vulnerable populations; 3) vaccine epidemiology, focusing on vaccine uptake and acceptability among adults, as well as on the impact of adult vaccination on healthcare utilization and medication use; 4) best research practices, including the optimization of knowledge synthesis methods. By integrating a range of methodological approaches, Dr. Sulis seeks to generate new and timely evidence that will inform decision-making and help shape clinical and public health practice changes across the research areas mentioned above.

Selected Publications

  1. Bigio J, Viscardi A, Gore G, Matteelli A, Sulis G. Risk of tuberculosis in individuals belonging to specific population groups: a scoping review. Eur Respir Rev. 2023 Jan 11; 32 (167):220127.
  2. Sulis G, Rodrigue V, Wolfson C, McMillan JM, Kirkland SA, Andrew MK, Basta NE. Pneumococcal vaccination uptake and missed opportunities for vaccination among Canadian adults: A cross-sectional analysis of the Canadian Longitudinal Study on Aging (CLSA). PLoS One. 2022 Oct 14;17(10):e0275923. 
  3. Sulis G, Tavaziva G, Gore G, Benedetti A, Solomons R, van Toorn R, Thee S, Day J, Verkuijl S, Brands A, Viney K, Masini T, Ahmad Khan F, Chiang SS. Comparative effectiveness of regimens for drug-susceptible tuberculous meningitis in children and adolescents: a systematic review and aggregate-level data meta-analysis. Open Forum Infect Dis. 2022 Jun;9(6): ofac108.
  4. Sulis G, Sayood S, Katukoori S, Bollam N, George I, Yaeger L, Chavez MA, Tetteh E, Yerrabelli S, Pulcini C, Harbarth S, Figueras A, Mertz D, Sharland M, Moja L, Huttner B, Gandra S. Exposure to WHO AWaRe antibiotics and isolation of multi-drug resistant bacteria: a systematic review and meta-analysis. Clin Microbiol Infect. Epub 2022 Mar 23.
  5. Sulis G, Batomen B, Kotwani A, Pai M, Gandra S. Sales of antibiotics and hydroxychloroquine in India during the COVID-19 epidemic: an interrupted time series analysis. PloS Med 2021; 18(7):e1003682. 

Diseases, conditions and populations of interest

Research and clinical approaches